VIA
ALT icon

Virtus Investment Advisers’s Altimmune ALT Stock Holding History

Virtus Investment Advisers’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Buy
51,743
+1,261
+2% +$5.35K 0.04% 440
2025
Q4 		$182K Buy
50,482
+34,568
+217% +$151K 0.05% 370
2025
Q3 		$60K Buy
15,914
+2,763
+21% +$10.7K 0.02% 436
2025
Q2 		$50.9K Sell
13,151
-5,965
-31% -$32.3K 0.02% 439
2025
Q1 		$95.6K Buy
+19,116
New +$121K 0.03% 427

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Virtus Investment Advisers's ALT Position: Q1 2026 in Review

Virtus Investment Advisers increased its Altimmune (ALT) stake by 2.5% in Q1 2026, buying an estimated $5.35K and bringing the position to 51,743 shares worth $159K. The position accounts for 0.04% of the portfolio, ranked #440.

Virtus Investment Advisers first reported a position in ALT in Q1 2025 and has held it in 5 quarters since. The position peaked at $182K in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Virtus Investment Advisers held 51,743 shares of Altimmune worth $159K as of Q1 2026.
  • Virtus Investment Advisers bought 1,261 Altimmune shares in Q1 2026, an estimated $5.35K.
  • Altimmune made up 0.04% of Virtus Investment Advisers's portfolio in Q1 2026, its #440 holding.
  • Virtus Investment Advisers first reported a position in Altimmune in Q1 2025 and has held it in 5 quarters since.
  • Virtus Investment Advisers's Altimmune position peaked at $182K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.